CORD-19:9717bf810e0bed806f32d85343b4210f37a9a319 / 6232-6469 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T31","span":{"begin":0,"end":237},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In general, formation of MV may begin within minutes after addition of an agonist, with the rise of intracellular calcium, which in platelets can be inhibited by calcium chelators (EDTA or EGTA) commonly used as anticoagulants (35, 36) ."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T19","span":{"begin":0,"end":237},"obj":"Epistemic_statement"}],"text":"In general, formation of MV may begin within minutes after addition of an agonist, with the rise of intracellular calcium, which in platelets can be inhibited by calcium chelators (EDTA or EGTA) commonly used as anticoagulants (35, 36) ."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T31","span":{"begin":0,"end":237},"obj":"Sentence"}],"text":"In general, formation of MV may begin within minutes after addition of an agonist, with the rise of intracellular calcium, which in platelets can be inhibited by calcium chelators (EDTA or EGTA) commonly used as anticoagulants (35, 36) ."}